In a statement, Infarmed orders the voluntary recall of batch no. 331670A of Bilaxten (bilastine) 6 milligrams\/millilitres (mg\/ml), eye drops, solution, with an expiry date of August 2027, corresponding to packages of one 5 ml vial.<\/p>\n
The recall of batch number 322950B of Lergonix (bilastine) 6 mg\/ml, eye drops, solution, registration number 5843750 (one 5 ml bottle), with an expiration date until the end of May 2027, is also ordered.<\/p>\n
\u201cIn view of the above, entities that have this batch of medication in \u2018stock\u2019 cannot sell, dispense or administer it, and must return it,\u201d it emphasizes, emphasizing that \u201cpatients who are using medications belonging to this batch should not interrupt treatment.\u201d<\/p>\n